Vigilant Biosciences® product is based on advanced patented technology, including an innovative methodology for assessing multiple biomarkers that, together with other clinical factors, can aid clinicians in the early detection of oral cancer. The clinically validated† test contributes to early and accurate† detection of oral cancer, potentially even before visual or physical indicators.